The company is awaiting further guidance from Health Canada after it filed a response in November to a notice of ...

Dr. Reddy’s has received an approval from India’s drug regulator to manufacture and sell the generic version of diabetes drug ...

Dr. Reddy’s has received an approval from India’s drug regulator to manufacture and sell the generic version of diabetes drug ...

The patent for Semaglutide, the active ingredient in Novo Nordisk's drugs Wegovy and Ozempic, expires in March 2026, allowing ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and in-depth features. Reclaim your full access. Click below to renew.

Indian drugmaker Dr Reddy's , which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval from the country's drug regulator to manufacture and ...

India, meanwhile, witnessed the launch of three global obesity blockbusters last year—Mounjaro, Wegovy, and Ozempic (approved for type-2 diabetes but widely used off-label for obesity). All three have ...

As GLP-1 drugs reshape India's weight-loss landscape, they may also be quietly rewriting reproductive outcomes—catching ...

The Better Business Bureau received multiple reports from Wisconsin consumers who were sold discounted diet medication.